HBsAg seroclearance in the natural history of chronic hepatitis B infection
Current Hepatitis Reports, ISSN: 1540-3416, Vol: 5, Issue: 1, Page: 23-26
2006
- 58Citations
- 41Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations58
- Citation Indexes57
- 57
- CrossRef12
- Clinical Citations1
- PubMed Guidelines1
- Captures41
- Readers41
- 30
- 10
Review Description
Hepatitis B surface antigen (HBsAg) seroclearance is a rare event that occurs in 0.1% to 2% of patients with chronic hepatitis B per year. Patients with HBsAg seroclearance have improvement of liver biochemistry and hepatic necroinflammation. The viral load gradually decreases with time, although some patients still have detectable intrahepatic hepatitis B virus DNA, mainly in the form of covalently closed circular DNA. There is no reduction of the risk of cirrhosis-related complications and hepatocellular carcinoma if HBsAg seroclearance occurs at an older age when cirrhosis has already been established. Copyright © 2006 by Current Science Inc.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33750362674&origin=inward; http://dx.doi.org/10.1007/s11901-006-0019-7; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33747661312&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16537043; http://link.springer.com/10.1007/s11901-006-0019-7; https://dx.doi.org/10.1007/s11901-006-0019-7; https://link.springer.com/article/10.1007%2Fs11901-006-0019-7; http://www.springerlink.com/index/10.1007/s11901-006-0019-7; http://www.springerlink.com/index/pdf/10.1007/s11901-006-0019-7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know